Docetaxel trihydrate is a potent anti-mitotic chemotherapy agent belonging to the taxane class, clinically indicated for the treatment of various solid tumors, including breast, non-small cell lung, prostate,… Read more
Docetaxel trihydrate is a potent anti-mitotic chemotherapy agent belonging to the taxane class, clinically indicated for the treatment of various solid tumors, including breast, non-small cell lung, prostate, gastric, and head and neck cancers. It functions by stabilizing microtubules, effectively disrupting the cell division process. To support the rigorous analytical demands of pharmaceutical development, this category provides high-quality reference standards of the active pharmaceutical ingredient, along with a comprehensive selection of its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories performing impurity profiling, method development, and validation to ensure the quality, safety, and consistency of therapeutic formulations. Chemists and analytical researchers rely on these standardized compounds to accurately identify and quantify degradation products and trace elements within complex drug matrices during the lifecycle of the product.